Quick Answer
NAD+ IV therapy delivers the coenzyme directly into your bloodstream over a slow infusion, which gives it close to full bioavailability and a large immediate rise in plasma NAD+. A subcutaneous NAD+ injection is absorbed more gradually from under the skin, so a smaller share reaches your bloodstream per dose, but it costs less, takes minutes instead of hours, and is easy to repeat on a regular schedule. IV suits people who want a bigger, occasional dose and don't mind the time and cost. Injections suit people who want a steady, sustainable rhythm. Research on both is still emerging, so we frame NAD+ as a supportive longevity tool rather than a treatment for any condition.
If you're deciding between an NAD+ injection and an NAD+ IV, the short version is this: the IV gets more of the molecule into your bloodstream in one sitting, and the injection is the cheaper, lower-effort option you can keep up week after week. Both deliver the same coenzyme. They just take different roads to get there, and the road you pick depends on your goals, your budget, and how much time you want to spend in a chair.
We offer both at Defiant in Lisle, and the honest answer to "which is better" is that neither wins across the board. Let's walk through how they actually differ so you can make the call that fits your life.
First, What NAD+ Actually Does
NAD+ is a coenzyme your cells can't function without. It sits at the center of how you turn food into energy, and it's the fuel that a family of repair and signaling enzymes (sirtuins and PARPs, if you want the names) burn through to do their jobs.1 When NAD+ is plentiful, those systems have what they need. When it runs low, they slow down.
Here's the part that gets people's attention. NAD+ levels drop as we age. Research suggests they can fall to roughly half of youthful levels by middle age, partly because an enzyme called CD38 ramps up and consumes more of your supply over time.1 That decline is one reason NAD+ has become such a talked-about molecule in the longevity world, and it's why people come in asking whether they should be topping it back up.
Restoring NAD+ directly, rather than waiting on your body to make more, is the whole idea behind both the IV and the injection. The only question is delivery.
How NAD+ IV Therapy Works
An NAD+ IV puts the coenzyme straight into a vein, which bypasses your gut and your skin entirely. That's why its bioavailability is essentially complete, and it's why the rise in plasma NAD+ is so dramatic. In a well-known pilot study, a single six-hour infusion of 750 mg raised participants' plasma NAD+ by nearly 400 percent, and levels then decline over the following day as tissues take up and use the molecule.2
The catch is the clock and the comfort. NAD+ has to go in slowly, because a fast infusion tends to bring on chest tightness, flushing, a racing heart, and nausea.3 None of that is dangerous, but it's genuinely unpleasant, and the fix is simply to slow the drip down. A meaningful NAD+ IV can run anywhere from one to several hours depending on the dose, so you're committing a real chunk of your day. Most people bring headphones, get comfortable, and treat it as downtime.
Who tends to reach for the IV? People doing an occasional high-dose reset, people who want the maximum single-session bump, and people who like the idea of a dedicated block of time rather than an ongoing routine.
How NAD+ Injections Work
A subcutaneous NAD+ injection goes into the fat just under your skin, usually the belly or thigh, and the coenzyme trickles into nearby capillaries over roughly the next half hour. You don't get the sudden spike an IV gives you. What you get instead is a gentler, more spread-out rise, and a much shorter appointment. The shot itself takes a minute.
Bioavailability lands lower than IV at an equivalent dose, but that gap matters less than it sounds once you factor in how you'd actually use it. Because injections are cheaper and quick, they're easy to repeat two or three times a week, and that steady cadence may produce more stable NAD+ levels over time than a single big infusion every few weeks. For a lot of people chasing a long-term longevity rhythm rather than a one-off, the sustainable option quietly wins.
The tradeoff is that you're doing it more often, and some people just don't love needles, even small ones. That's a fair reason to lean toward the IV instead.
NAD+ Injection vs IV: Side by Side
| NAD+ Injection (Subcutaneous) | NAD+ IV Infusion | |
|---|---|---|
| Bioavailability | Lower than IV (gradual absorption) | Essentially complete (direct to bloodstream)2 |
| Peak NAD+ rise | Gradual, lower peak | Fast, high peak (~400% in one 6-hr study)2 |
| Time per session | A few minutes | One to several hours (slow drip) |
| Comfort | Small pinch under the skin | Slower drip avoids flushing and nausea3 |
| Cost per session | Lower | Higher |
| Best for | Steady, repeatable longevity routine | Occasional high-dose sessions |
| Sustainability | Easy to keep up long-term | Bigger time and cost commitment |
So Which Should You Pick?
Start with what you're actually after. If you want the largest single hit of NAD+ and you don't mind giving up a few hours now and then, the IV is the tool for that job. If you'd rather build NAD+ support into your week without reorganizing your calendar or your budget around it, injections are almost always the more realistic path, and the more consistent one.
A fair number of our clients end up using both. They'll do an IV as an occasional reset, then hold their levels with injections in between. Neither approach requires the other, and there's no single protocol that's right for everyone, which is exactly why we start with a consultation and your goals rather than a package off a menu.
One honest caveat worth repeating: the research on NAD+ supplementation in humans is still young. The pharmacokinetics are well described, meaning we know the molecule gets in and raises your levels, but the long-term outcome studies people really want are still being done.4 We think NAD+ is a promising piece of a longevity plan. We don't think anyone should sell it to you as a cure for anything.
How Defiant Handles NAD+
At our Lisle clinic we offer NAD+ as both a subcutaneous injection and an IV infusion, and we serve clients from Naperville, Downers Grove, Wheaton, and across Chicago's western suburbs. NAD+ tends to work best as part of a broader plan rather than a standalone fix, so we usually look at it alongside the rest of what you're doing for recovery, energy, and healthy aging. If you're already thinking about peptides, HBOT, or IV nutrient therapy, NAD+ often slots in naturally next to them.
Whatever you choose, it's medically supervised, dosed to your goals, and adjusted as we go.
- NAD+ IV delivers close to full bioavailability and a large, fast rise in plasma NAD+, but it takes hours and costs more per session.
- NAD+ injections deliver a smaller share per dose than an IV but cost less and take minutes, which makes them easy to repeat on a steady schedule.
- IV suits occasional high-dose sessions; injections suit a sustainable long-term rhythm, and many people use both.
- NAD+ has to be infused slowly, because fast IV delivery can cause flushing, chest tightness, and nausea.
- Research on NAD+ supplementation is still emerging, so we treat it as a supportive longevity tool, not a treatment for any condition.
Frequently Asked Questions
Restore NAD+ Your Way.
Injection or IV, we'll help you pick the delivery that fits your goals, your schedule, and your budget. Every NAD+ protocol at Defiant is medically supervised and built around you.
Keep Reading
Last updated July 15, 2026.
References
- Schultz MB, Sinclair DA. Why NAD+ Declines during Aging: It's Destroyed. Cell Metabolism. 2016;23(6):965-966. PMC
- Grant R, Berg J, Mestayer R, et al. A Pilot Study Investigating Changes in the Human Plasma and Urine NAD+ Metabolome During a 6 Hour Intravenous Infusion of NAD+. Frontiers in Aging Neuroscience. 2019;11:257. Frontiers
- Intravenous infusion of nicotinamide adenine dinucleotide (NAD+) versus nicotinamide riboside (NR): a retrospective tolerability pilot study in a real-world setting. Frontiers in Aging. 2026. PMC
- Randomized, placebo-controlled, pilot clinical study evaluating acute Niagen+ IV and NAD+ IV in healthy adults (preprint). medRxiv. 2024. medRxiv